JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0%
Sat, 1 Feb

JUBILANT LIFE SCIENCES has announced its results for the quarter ended December 2019. Here is a detailed performance review of the same:

JUBILANT LIFE SCIENCES Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-18*
3
Sep-19*
3
Dec-19*
QoQ ChangeYoY Change
Net SalesRs m23,77122,65923,1522.2%-2.6%
Other incomeRs m29012360-50.8%-79.2%
TurnoverRs m24,06122,78223,2121.9%-3.5%
ExpensesRs m18,83817,97518,0780.6%-4.0%
Gross profitRs m4,9334,6854,7280.9%-4.2%
DepreciationRs m9841,1681,135-2.9%15.3%
InterestRs m6837167200.5%5.5%
Profit before taxRs m3,5562,9222,9330.4%-17.5%
TaxRs m881428899109.9%2.1%
Profit after taxRs m2,6752,4942,034-18.4%-24.0%
Gross profit margin%20.820.720.4
Effective tax rate%24.814.730.7
Net profit margin%11.110.98.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 2.6% on a year-on-year (YoY) basis. The expenses were down by 4.0% YoY during the same period.
  • The company's operating profit declined by 4.2% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 20.4% in 3QFY20 as against 20.8% in 3QFY19.
  • Depreciation charges increased by 15.3% and finance costs increased by 5.5% YoY, respectively.
  • Other income declined by 79.2% YoY during the quarter.
  • Net profit for the quarter declined by 24.0% YoY. Net profit margins during the quarter declined from 11.1% in 3QFY19 to 8.8% in 3QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 2.2% on a quarter-on-quarter (QoQ) basis. The expenses were up by 0.6% QoQ during the same period.
  • The company's operating profit increased by 0.9% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 20.4% in 3QFY20 as against 20.7% in 2QFY19.
  • Net profit for the quarter declined by 18.4% QoQ, while net profit margins declined from 10.9% in 2QFY19 to 8.8% in 3QFY20.

To see how JUBILANT LIFE SCIENCES has performed over the last eight quarters,please visit here.

SPECIAL OFFER: How to Claim 1 Year FREE ACCESS to Hidden Treasure...

JUBILANT LIFE SCIENCES Share Price Performance

Over the last one year,JUBILANT LIFE SCIENCES share price has moved down from Rs 711.6 to Rs 570.6, registering a Loss of Rs 141.0 or around 19.8%.

Meanwhile, the S&P BSE OIL & GAS Index is trading at Rs 14,030.1 (up 0.8%). Over the last one year it has moved up from 13,633.8 to 14,030.1, a gain of 396 points (up 2.9%).

Overall, the S&P BSE SENSEX is up 12.6% over the year.

Current Valuations

At the current price of Rs 570.6, the price to earnings (P/E) ratio of JUBILANT LIFE SCIENCES stands at 16.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 1.9 times.

Equitymaster requests your view! Post a comment on "JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0%". Click here!

  

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

More Views on News

Most Popular

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver?(Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

Forget the Nifty and Sensex for the Next 1 or 2 Years and Focus on These Stocks(Profit Hunter)

Aug 6, 2020

Stocks from the essential small cap space are likely to be outperformers over the next 1 or 2 years.

This 20 Year Cycle Suggests Gold is Set for an August Rally(Profit Hunter)

Jul 31, 2020

The real reason why gold prices will go up more.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 13, 2020 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - ACTAVIS COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS